If a genetic therapy was created to cure sickle cell disease, how might this affect the productivity and earnings of an individual with the disease? How might this change also affect wider economic disparities? PRECISIONheor’s Marlon Graf (Senior Research Economist), Rifat Tuly (Research Scientist), and Jeff Sullivan (Senior Director) recently constructed a model to answer these impactful questions.
Precision will be at this year’s BIO International Convention from June 13 – 16 in San Diego, California. Connect with our team of experts throughout the event by joining our expert session, meeting our team at the booth, or attending our private Cell & Gene reception co-hosted by Precision ADVANCE and the Alliance for Regenerative Medicine (ARM).